We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




X-Ray Techniques Probe the Clostridium Difficile Surface Layer

By LabMedica International staff writers
Posted on 11 Mar 2009
A team of molecular microbiologists has begun to shed light on the structural mechanism used by the pathogenic bacterium Clostridium difficile to adhere to and infect human enteric tissue.

Investigators at Imperial College (London, United Kingdom) used X-ray crystallography techniques to produce both high- and low-resolution images of the C. More...
difficile surface layer (S-layer). The S-layer contains a high-molecular-weight S-layer protein (HMW SLP) and its low-molecular-weight partner protein (LMW SLP).

Results published in the March 1, 2009, issue of the journal Molecular Microbiology revealed that the two types of protein formed a tightly associated noncovalent complex, the H/L complex. The 2.4-angstrom X-ray crystal structure of a shortened derivative of the LMW SLP revealed two domains. Domain 1 had a two-layer sandwich architecture while domain 2, predicted to orientate towards the external environment, contained a novel fold.

Small-angle X-ray scattering analysis of the H/L complex showed an elongated molecule, with the two SLPs arranged "end-to-end" interacting with each other through a small contact area. The way the LMW SLPs - which showed high sequence diversity - were aligned revealed a core of conserved residues. This type of structure could reflect functional conservation, while allowing for immune evasion through the sequence variation.

Dr. Neil Fairweather, professor of cell and molecular biology at Imperial College said, "This is the first time anyone has gained detailed information about the molecular structure of [the] C. difficile protective 'jacket,' because analyzing the two protein components is painstakingly difficult work. We are confident that continuing this work to better understand the formation of this protective coat and its exact function will reveal new targets for effective drugs to beat this dangerous pathogen, and could even lead to an effective vaccine."

Related Links:
Imperial College



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers

Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.